27 July 2022
Pharmaceutical companies will be forced to disclose their drug development costs, including for cancer therapies, under the drug price transparency mechanism, says Khairy Jamaluddin.
Tag: medicine price controls
7 February 2022
Pharma MNCs may deprioritise Malaysia into a “Wave 3” country, like Vietnam and South Africa, without access to innovative medicines if drug price controls are implemented.
2 February 2022
A cost-benefit analysis estimates T20 patients with private insurance may save RM1.6 billion yearly, four times higher than RM368 million for M40 and 22 times higher than RM73 million for B40.
31 January 2022
A cost-benefit analysis finds drug price controls may shutter 2,600 clinics and cause pay cuts, salary freezes, or layoffs of 91,000 to 136,000 private health care jobs.
23 October 2020
MOH only regulates medical professional fees (consultation and procedural fees) in private health facilities, not hospital fees.
17 July 2020
MOH and KPDNHEP are preparing a price control mechanism for medicines, says Dr Adham Baba.
6 March 2020
PhRMA says medicine price ceilings may delay patient access to new treatments.
21 January 2020
The Health Ministry also pans a survey that found Malaysia has among the cheapest prices globally for some popular prescription drugs.
16 January 2020
Majority of the drugs affected by the Philippines’ maximum retail price scheme are new treatments for cancer, diabetes, and cardiovascular conditions.
14 January 2020
Companies may benefit from a higher sales volume, offsetting some losses from lower medicine prices.